Brain stress systems in the amygdala and addiction

[1]  G. Koob.  Neurobiological substrates for the dark side of compulsivity in addiction , 2009, Neuropharmacology.

[2]  G. Koob,et al.  PRECLINICAL STUDY: Corticotropin‐releasing factor‐1 receptor antagonists decrease heroin self‐administration in long‐ but not short‐access rats , 2009, Addiction biology.

[3]  G. Koob,et al.  The α1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration , 2009, Pharmacology Biochemistry and Behavior.

[4]  G. Koob.  A Role for Brain Stress Systems in Addiction , 2008, Neuron.

[5]  G. Koob,et al.  α1-Noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access , 2008, European Neuropsychopharmacology.

[6]  R. Rimondini,et al.  PRECLINICAL STUDY: Long‐lasting tolerance to alcohol following a history of dependence , 2008, Addiction biology.

[7]  G. Koob,et al.  alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. , 2008, Alcohol.

[8]  G. Koob,et al.  MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist , 2008, Pharmacology Biochemistry and Behavior.

[9]  P. Hipskind,et al.  Upregulation of Voluntary Alcohol Intake, Behavioral Sensitivity to Stress, and Amygdala Crhr1 Expression Following a History of Dependence , 2008, Biological Psychiatry.

[10]  M. Le Moal,et al.  Addiction and the brain antireward system. , 2008, Annual review of psychology.

[11]  G. Koob,et al.  CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. , 2008, Psychopharmacology.

[12]  G. Koob,et al.  CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats , 2008, Psychopharmacology.

[13]  L. Parsons,et al.  CRF–CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats , 2007, Proceedings of the National Academy of Sciences.

[14]  G. Koob,et al.  A key role for corticotropin-releasing factor in alcohol dependence , 2007, Trends in Neurosciences.

[15]  P. Hipskind,et al.  3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism , 2007, The Journal of Neuroscience.

[16]  G. Koob,et al.  Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats , 2007, Biological Psychiatry.

[17]  S. Matta,et al.  Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain , 1997, Endocrine.

[18]  W. Vale,et al.  The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress , 2006, Dialogues in clinical neuroscience.

[19]  Antonio Alcaro,et al.  Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex , 2006, Neuroreport.

[20]  G. Koob,et al.  Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats , 2006, The Journal of Neuroscience.

[21]  D. Winder,et al.  Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis , 2006, Neuropharmacology.

[22]  Donald W. Pfaff,et al.  Brain Arousal and Information Theory: Neural and Genetic Mechanisms , 2005 .

[23]  G. Koob,et al.  Plasticity of reward neurocircuitry and the 'dark side' of drug addiction , 2005, Nature Neuroscience.

[24]  D. Overstreet,et al.  Prior Multiple Ethanol Withdrawals Enhance Stress-Induced Anxiety-Like Behavior: Inhibition by CRF1- and Benzodiazepine-Receptor Antagonists and a 5-HT1a-Receptor Agonist , 2005, Neuropsychopharmacology.

[25]  C. Ehlers,et al.  Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: Relation to anxiety-like and depressive-like behavior , 2005, Neuropeptides.

[26]  H. Becker.  Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures , 1994, Psychopharmacology.

[27]  G. Koob,et al.  The roles of urocortins 1, 2, and 3 in the brain , 2005 .

[28]  G. Aston-Jones,et al.  β-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats , 2005, Psychopharmacology.

[29]  G. Koob,et al.  CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat , 2005, Psychopharmacology.

[30]  G. Koob,et al.  Buprenorphine and a CRF1 Antagonist Block the Acquisition of Opiate Withdrawal-Induced Conditioned Place Aversion in Rats , 2005, Neuropsychopharmacology.

[31]  L. Parsons,et al.  Increased GABA Release in the Central Amygdala of Ethanol-Dependent Rats , 2004, The Journal of Neuroscience.

[32]  John T. Williams,et al.  Noradrenaline Triggers GABAA Inhibition of Bed Nucleus of the Stria Terminalis Neurons Projecting to the Ventral Tegmental Area , 2004, The Journal of Neuroscience.

[33]  G. Koob,et al.  Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. , 2004, Alcoholism, clinical and experimental research.

[34]  S. D. Moore,et al.  Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors , 2004, Science.

[35]  D. Overstreet,et al.  Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors , 2004, Pharmacology Biochemistry and Behavior.

[36]  D. Overstreet,et al.  SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. , 2004, Alcohol.

[37]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[38]  T. Baker,et al.  Potentiation of ethanol withdrawal by prior dependence , 1979, Psychopharmacology.

[39]  G. Koob.  Allostatic view of motivation: implications for psychopathology. , 2004, Nebraska Symposium on Motivation. Nebraska Symposium on Motivation.

[40]  R. Hale,et al.  Ethanol-induced locomotor stimulation in C57BL/6 mice following RO15-4513 administration , 2004, Psychopharmacology.

[41]  B. Kissin,et al.  Modifications in the response to alcohol following the establishment of physical dependence , 2004, Psychopharmacologia.

[42]  R. Bevins,et al.  Motivational factors in the etiology of drug abuse , 2004 .

[43]  S. Matta,et al.  Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study , 2003, Neuropharmacology.

[44]  S. File,et al.  Corticotropin releasing factor antagonist, α-helical CRF9–41, reverses nicotine-induced conditioned, but not unconditioned, anxiety , 2003, Psychopharmacology.

[45]  R. Hauger,et al.  International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands , 2003, Pharmacological Reviews.

[46]  G. Koob,et al.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. , 2003, Alcohol.

[47]  J. Pastor,et al.  [Neurobiology of addiction to drugs of abuse]. , 2003, Revista de neurologia.

[48]  Y. Shaham,et al.  The reinstatement model of drug relapse: history, methodology and major findings , 2003, Psychopharmacology.

[49]  F. Weiss,et al.  Additive Effect of Stress and Drug Cues on Reinstatement of Ethanol Seeking: Exacerbation by History of Dependence and Role of Concurrent Activation of Corticotropin-Releasing Factor and Opioid Mechanisms , 2002, The Journal of Neuroscience.

[50]  R. Jaenisch,et al.  Brain-Derived Neurotrophic Factor Is Essential for Opiate-Induced Plasticity of Noradrenergic Neurons , 2002, The Journal of Neuroscience.

[51]  C. Hodge,et al.  Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake , 2002, Pharmacology Biochemistry and Behavior.

[52]  J. Vaughan,et al.  Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression , 2002, The Journal of Neuroscience.

[53]  R. Rimondini,et al.  Long‐lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  S. Matta,et al.  Norepinephrine Secretion in the Hypothalamic Paraventricular Nucleus of Rats during Unlimited Access to Self-Administered Nicotine: An In Vivo Microdialysis Study , 2001, The Journal of Neuroscience.

[55]  M. Wilson,et al.  Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal , 2001, Molecular Psychiatry.

[56]  C. Donaldson,et al.  Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[57]  L. Parsons,et al.  Compulsive Drug‐Seeking Behavior and Relapse , 2001 .

[58]  J. Vaughan,et al.  Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[60]  Vanya Qui ones-Jenab.  The biological basis of cocaine addiction , 2001 .

[61]  C. Heyser,et al.  Excessive Ethanol Drinking Following a History of Dependence: Animal Model of Allostasis , 2000, Neuropsychopharmacology.

[62]  Nicole C. Rust,et al.  Ethanol-Associated Behaviors of Mice Lacking Norepinephrine , 2000, The Journal of Neuroscience.

[63]  G. Aston-Jones,et al.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion , 2000, Nature.

[64]  G. Koob,et al.  Corticotropin-releasing factor, norepinephrine, and stress , 1999, Biological Psychiatry.

[65]  H. Akil,et al.  Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: Evidence for their selective activation by interleukin‐1β , 1999, The Journal of comparative neurology.

[66]  G. Koob,et al.  Corticotropin-releasing factor antagonist attenuates the “anxiogenic-like” effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats , 1999, Psychopharmacology.

[67]  F Weiss,et al.  In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self‐administering rats , 1999, Synapse.

[68]  G. Koob,et al.  Clonidine Blocks Acquisition But not Expression of Conditioned Opiate Withdrawal in Rats , 1998, Neuropsychopharmacology.

[69]  E. V. Van Bockstaele,et al.  Amygdaloid Corticotropin‐Releasing Factor Targets Locus Coeruleus Dendrites: Substrate for the Co‐ordination of Emotional and Cognitive Limbs of the Stress Response , 1998, Journal of neuroendocrinology.

[70]  H Selye,et al.  A syndrome produced by diverse nocuous agents. 1936. , 1998, The Journal of neuropsychiatry and clinical neurosciences.

[71]  H. Annis,et al.  Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. , 1998, Addictive behaviors.

[72]  B. Kobilka,et al.  Insights from in vivo modification of adrenergic receptor gene expression. , 1998, Annual review of pharmacology and toxicology.

[73]  G F Koob,et al.  Drug abuse: hedonic homeostatic dysregulation. , 1997, Science.

[74]  G. Koob,et al.  Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. , 1997, Science.

[75]  R. Stout,et al.  Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and results. The Relapse Research Group. , 1996, Addiction.

[76]  S. Maisto,et al.  Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt's relapse taxonomy. , 1996, Addiction.

[77]  G. Koob,et al.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[78]  Z. Sarnyai,et al.  Brain corticotropin-releasing factor mediates ‘anxiety-like’ behavior induced by cocaine withdrawal in rats , 1995, Brain Research.

[79]  G. Koob,et al.  Suppression of corticotropin‐releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal , 1995, Behavioural pharmacology.

[80]  G. Aghajanian,et al.  Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus , 1994, Brain Research Bulletin.

[81]  B. Mason,et al.  A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol Dependence , 1994 .

[82]  S. Foote,et al.  The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responses a , 1993, Annals of the New York Academy of Sciences.

[83]  S. Matta,et al.  Detection by in vivo microdialysis of nicotine-induced norepinephrine secretion from the hypothalamic paraventricular nucleus of freely moving rats: dose-dependency and desensitization. , 1993, Endocrinology.

[84]  M. Cassell,et al.  Intrinsic GABAergic neurons in the rat central extended amygdala , 1993, The Journal of comparative neurology.

[85]  G. Koob,et al.  Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal , 1993, Brain Research.

[86]  M. Page,et al.  Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor , 1991, Brain Research.

[87]  P. Kalivas,et al.  The basal forebrain : anatomy to function , 1991 .

[88]  L. Heimer,et al.  Piecing together the puzzle of basal forebrain anatomy. , 1991, Advances in experimental medicine and biology.

[89]  G. Koob,et al.  Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal , 1990, Neuroscience.

[90]  L. Heimer,et al.  New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: The striatopallidal, amygdaloid, and corticopetal components of substantia innominata , 1988, Neuroscience.

[91]  J. T. Reason,et al.  Handbook of Life Stress, Cognition and Health , 1988 .

[92]  P. Sterling,et al.  Allostasis: A new paradigm to explain arousal pathology. , 1988 .

[93]  I. Ferrier,et al.  Distribution of corticotropin-releasing factor-like immunoreactivity in human brain , 1987, Neuropeptides.

[94]  I. Assenmacher,et al.  Immunocytochemical evidence for stimulatory control by the ventral noradrenergic bundle of parvocellular neurons of the paraventricular nucleus secreting corticotropin releasing hormone and vasopressin in rats , 1986, Brain Research.

[95]  S. Roelofs.  Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. , 1985, Alcohol.

[96]  P. Cushman,et al.  Alcohol withdrawal syndromes: clinical management with lofexidine. , 1985, Alcoholism, clinical and experimental research.

[97]  S. Otsuki,et al.  Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. , 1983, Biological psychiatry.

[98]  G. Sedvall,et al.  Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. , 1983, Alcoholism, clinical and experimental research.

[99]  L. Swanson,et al.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. , 1983, Neuroendocrinology.

[100]  C. Alling,et al.  Studies on duration of a late recovery period after chronic abuse of ethanol , 1982, Acta psychiatrica Scandinavica.

[101]  G. Sedvall,et al.  Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. , 1981, Science.

[102]  S. Burchfield.  The Stress Response: A New Perspective , 1979, Psychosomatic medicine.

[103]  T. E. Werner,et al.  Reinforcement with intragastric infusions of ethanol: Blocking effect of FLA 57 , 1979, Pharmacology Biochemistry and Behavior.

[104]  S. T. Mason,et al.  Noradrenaline and ethanol intake in the rat , 1979, Neuroscience Letters.

[105]  S. Ogren,et al.  Noradrenergic mediation of the positive reinforcing properties of ethanol: I. Suppression of ethanol consumption in laboratory rats following dopamine-beta-hydroxylase inhibition. , 1977, Archives internationales de pharmacodynamie et de therapie.

[106]  Z. Amit,et al.  The effects of selective catecholamine depletions by 6-hydroxydopamine on ethanol preference in rats , 1977, Neuroscience Letters.

[107]  H I Hershon,et al.  Alcohol withdrawal symptoms and drinking behavior. , 1977, Journal of studies on alcohol.

[108]  H. Selye.  A Syndrome produced by Diverse Nocuous Agents , 1936, Nature.

[109]  J. Johnston.  Further contributions to the study of the evolution of the forebrain , 1923 .